Private Equity
In his new role, Johnson will support the work associated with new opportunities within the healthcare technology sector.
2 min read · 22 September 2022
The sellers include InTandem Capital Partners.
1 min read · 22 September 2022
ProtaGene is a CRO partner for the biopharmaceutical and cell and gene therapy industries.
1 min read · 21 September 2022
The size of the deal is about $1.37 billion.
2 min read · 20 September 2022
Churchill is an investment-specialist affiliate of Nuveen, the asset manager of TIAA.
1 min read · 20 September 2022
CIBC Innovation Banking has provided $60 million of new debt financing to TransMedics Group.
1 min read · 16 September 2022
In conjunction with WindRose’s investment, TWRx acquired SRX, a provider of pharmaceutical rebate management services for the skilled nursing and LTC industry.
2 min read · 16 September 2022
'As we think about the massive amount of paper still in healthcare, the inefficiency of payment transfers and payment modalities, that’s another huge avenue for us,' said FTV’s Mason.
6 min read · 15 September 2022
Moving forward, GI Alliance's physician owners, led by CEO Dr. James Weber, own a controlling equity stake in GIA.
2 min read · 15 September 2022
Veda Corporate Advisors was financial advisor to SHPL and its shareholders.
1 min read · 14 September 2022
